{
    "symbol": "MDT",
    "quarter": 1,
    "year": 2023,
    "date": "2022-08-23 12:43:15",
    "content": " By segment and on an organic basis, we continue to expect cardiovascular to grow 5.5% to 6.5%, Medical Surgical to now grow 0.75% to 2.75%, given increased volume-based procurement in many of the Chinese provinces, Neuroscience to now grow 4.75% to 5.75%, given a slightly lower outlook for the Neuromodulation market; and diabetes to now decline 3% to 6%, given stronger growth in international markets. Next question, please, Brad. Next question, please, Brad. Next question, please, Brad. Next question, please, Brad. Next question, please, Brad."
}